ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2580

High-intensity Resistance Training Improves Quality of Life, Muscle Endurance and Strength in Patients with Myositis

Kasper Jensen1, Per Aagaard2, Charlotte Suetta3, Jakob Nielsen2, Rune Bech4, Henrik Schrøder1, Casper Simonsen1, Jan Christensen1 and Louise Pyndt Diederichsen5, 1University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark, 2University of Southern Denmark, Odense, Denmark, 3Bispebjerg Hospital, Copenhagen, Denmark, 4Zealand University Hospital, Koege, Dragør, Denmark, 5University Hospital of Copenhagen, Rigshospitalet, Dragør, Denmark

Meeting: ACR Convergence 2023

Keywords: exercise, Intervention, Myopathies, physical function

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 15, 2023

Title: Abstracts: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science II

Session Type: Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose: Myositis is associated with muscle impairment, which impacts quality of life. The purpose of this study was to investigate the effects of high-intensity strength training on quality of life, functional capacity, muscle strength and disease-related measures in patients with myositis.

Methods: Using a randomized control trial design (NCT04486261), 32 patients with established and stable myositis, were randomly allocated to 16 weeks of high-intensity strength training (HRT) or 16 weeks of baseline activity levels (CON). The primary outcome was quality of life (Short Form-36, SF-36) – physical component summary (PCS). Secondary outcomes included SF36 – mental component summary (MCS), functional capacity measures (e.g., 2-minute walk test (2MWT), 30-s Sit-To-Stand (30-STS), Timed-Up-&-GO (TUG) and Functional Index 3 (FI3)), maximal leg extensor power (LEP) and disease-related measures (Physician Global Activity (PhGA), Patient Global Activity (PtGA), Extramuscular Global Assessment (EMGA), Creatine Kinase (CK), Health Assessment Questionnaire (HAQ), Physician Global Damage (PhGD), Patient Global Damage (PtGD), and Manual Muscle Testing 8 (MMT8)).

Results: The primary outcome PCS showed an improvement in favour of HRT with a between-group difference of 5.33 (0.61;10.05) (p=0.03). Further, FI3 showed a between-group difference with greater gains of HRT (11.49 (3.37;19.60) (p=0.04)). Within-group increases in other functional capacity measures were observed with HRT (30-s STS, 6.5%, p=0.03; TUG, 12.9%, p< 0.0001; 2MWT, 4.9%, p=0.008; LEP, 14.2%, p=0.04). HRT also resulted in a between-group improvement in MMT8 (1.30 (0.09;2.51) (p=0.04)). Finally, IMACS’s physician global damage decreased by 27.7% (p=0.02), and patient global damage decreased by 47.2% (p=0.03), within the HRT group (Table 1).

Conclusion: Improvement in physical component of quality of life was observed following 16 weeks of strength training in myositis patients. Likewise, improvements in muscle endurance by FI3 and strength by MMT8 were significantly higher in TRAIN compared to CON. No increases in disease activity or damage were observed. These results indicate that high-intensity strength training is well tolerated and positively impacts patients with established myositis.

Supporting image 1

Data are presented as means and 95% confidence intervals in parentheses. HRT: high-intensity resistance trained; CON: control; 2MWT: 2-minute walk test; 30 STS: 30 second Sit To Stand; TUG: Timed Up and Go; FI3: Functional Index 3; LEP: Leg Power; PhGA: physician global activity; PtGA: patient global Activity; EMGA: Extramuscular global assessment; MMT8: Manual muscle testing 8; HAQ: Health assessment questionnaire; CK: Creatine kinase; PhGD: physician global damage; PtGD: patient global damage. Bold font means significant. Significant levels set at p=0.05.


Disclosures: K. Jensen: None; P. Aagaard: None; C. Suetta: None; J. Nielsen: None; R. Bech: None; H. Schrøder: None; C. Simonsen: None; J. Christensen: None; L. Diederichsen: None.

To cite this abstract in AMA style:

Jensen K, Aagaard P, Suetta C, Nielsen J, Bech R, Schrøder H, Simonsen C, Christensen J, Diederichsen L. High-intensity Resistance Training Improves Quality of Life, Muscle Endurance and Strength in Patients with Myositis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/high-intensity-resistance-training-improves-quality-of-life-muscle-endurance-and-strength-in-patients-with-myositis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/high-intensity-resistance-training-improves-quality-of-life-muscle-endurance-and-strength-in-patients-with-myositis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology